Liminatus Pharma

(NASDAQ) LIMN

Current Price$0.14

Market Cap$7.21M

Since IPO (2021)-99%

5 YearN/A

1 Year-98%

1 Month-27%

Liminatus Pharma Financials at a Glance

Market Cap

$7.21M

Revenue (TTM)

$0.00

Net Income (TTM)

-$11.00M

EPS (TTM)

-$0.40

P/E Ratio

-0.36

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Price

$0.14

Volume

3,534,996

Open

$0.17

Price

$0.14

Volume

3,534,996

Open

$0.17

Previous Close

$0.14

Daily Range

$0.13 - $0.20

52-Week Range

$0.10 - $9.38

Estimated Earnings Date

Jun 30, 2026

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Price

$0.14

Volume

3,534,996

Open

$0.17

Previous Close

$0.14

Daily Range

$0.13 - $0.20

52-Week Range

$0.10 - $9.38

Estimated Earnings Date

Jun 30, 2026

LIMN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Liminatus Pharma

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Chris Kim

Website

liminatuspharma.com

Headquarters

La Palma, CA 90623, US

LIMN Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

215.73%

Return on Capital

N/A

Return on Assets

-394.33%

Earnings Yield

-2.78%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.21M

Shares Outstanding

50.61M

Volume

3.53M

Avg. Volume

20.43M

Financials (TTM)

Gross Profit

-$518.00

Operating Income

-$3.80M

EBITDA

-$10.88M

Operating Cash Flow

-$11.98M

Capital Expenditure

-$13.11K

Free Cash Flow

-$11.99M

Cash & ST Invst.

$1.91M

Total Debt

$1.44M

Liminatus Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$518.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$7.21M

N/A

Market Cap/Employee

$2.40M

N/A

Employees

N/A

Net Income

-$1.12M

-440572.2%

EBITDA

-$1.10M

-1058.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$1.91M

N/A

Total Debt

$1.44M

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$1.44M

N/A

Return on Assets

-3.94%

N/A

Return on Invested Capital

38.36%

N/A

Free Cash Flow

-$2.02M

-1164.4%

Operating Cash Flow

-$2.02M

-1164.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

JSPRJasper Therapeutics, Inc.

JSPRJasper Therapeutics, Inc.$0.43-5.76%

EVAXEvaxion Biotech A/S

EVAXEvaxion Biotech A/S$3.41+6.56%

DYAIDyadic International, Inc.

DYAIDyadic International, Inc.$0.94-7.79%

MURAMural Oncology plc

MURAMural Oncology plc$2.04+0.00%

GBIOGeneration Bio Co.

GBIOGeneration Bio Co.$5.34+0.00%

SABSSAB Biotherapeutics, Inc.

SABSSAB Biotherapeutics, Inc.$3.92+1.03%

BTAIBioXcel Therapeutics, Inc.

BTAIBioXcel Therapeutics, Inc.$1.38+0.73%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92-0.01%

TAT&T

TAT&T$20.58+0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.30-0.15%

CLROClearOne

CLROClearOne$6.48+1.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.35-0.05%

ONDSOndas

ONDSOndas$7.41-0.06%

NOKNokia

NOKNokia$12.07-0.07%

Questions About LIMN

What is the current price of Liminatus Pharma?

Liminatus Pharma is trading at $0.14 per share.

What is the 52-week range for Liminatus Pharma?

Over the past 52 weeks, Liminatus Pharma has traded between $0.10 and $9.38.

How much debt does Liminatus Pharma have?

As of the most recent reporting period, Liminatus Pharma reported total debt of $1.44M.

How much cash does Liminatus Pharma have on hand?

Liminatus Pharma reported $1.91M in cash and cash equivalents in its most recent financial results.

What is Liminatus Pharma’s dividend yield?

Liminatus Pharma does not currently have a dividend yield.

Liminatus Pharma

Liminatus Pharma Financials at a Glance

LIMN News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Liminatus Pharma

LIMN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Liminatus Pharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About LIMN

What is the current price of Liminatus Pharma?

What is the 52-week range for Liminatus Pharma?

How much debt does Liminatus Pharma have?

How much cash does Liminatus Pharma have on hand?

What is Liminatus Pharma’s dividend yield?

Premium Investing Services